Vincenzo Quagliariello

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" — Italy

Medicine · Health Sciences

31h-index2.6kcitations94works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chemotherapy-induced cardiotoxicity and mitigation(27), Metabolism, Diabetes, and Cancer(13), Diabetes Treatment and Management(12), Cancer Immunotherapy and Biomarkers(7), Cancer, Lipids, and Metabolism(6)

Publications94 total

Fusobacteriumnucleatum: Pathophysiological and Clinical Involvement in Inflammatory Bowel Diseases, Colorectal Cancer and Cardiovascular Diseases
Cancers·2025Open Access
Healthcare Management in Cardio-Oncology, Clinical Strategies and Future Perspectives: A Narrative Review
Healthcare·2025Open Access
Fusobacterium Nucleatum in Colorectal Cancer: Relationship Among Immune Modulation, Potential Biomarkers and Therapeutic Implications
International Journal of Molecular Sciences·2025· 2 citedOpen Access
Time to Combinatorial Regimens: SGLT2i and PCSK9i in High-Risk Cardio-Oncology Patients
Journal of Cardiovascular Pharmacology·2025· 1 cited
The Crucial Role of Tinzaparin in Managing Venous Thromboembolism in the Cancer Population
Journal of Clinical Medicine·2025· 2 citedOpen Access
Factor XI and Cancer: Physiopathological Linkage and Clinical Perspectives
Journal of Clinical Medicine·2025· 3 citedOpen Access
SGLT2i Dapagliflozin in primary prevention of chemotherapy induced cardiotoxicity in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy +/- trastuzumab: rationale and design of the multicenter PROTECT trial
Cardio-Oncology·2025· 2 citedOpen Access
Investigating the Impact of Fusobacterium nucleatum on Oxidative Stress, Chemoresistance, and Inflammation in Inflammatory Bowel Disease and Colorectal Cancer: Rationale and Design of a Clinical Trial
International Journal of Molecular Sciences·2025· 3 citedOpen Access
Atrial Fibrillation and Cancer: Pathophysiological Mechanism and Clinical Implications
Journal of Clinical Medicine·2025· 7 citedOpen Access
PCSK9 Inhibitor Inclisiran Attenuates Cardiotoxicity Induced by Sequential Anthracycline and Trastuzumab Exposure via NLRP3 and MyD88 Pathway Inhibition
International Journal of Molecular Sciences·2025· 7 citedOpen Access
Impact of Proton Pump Inhibitor Use on Progression-Free and Overall Survival in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis of Recent Studies
Cancers·2025· 2 citedOpen Access
Heart Failure and Wide QRS: Clinical and Pharmacological Perspectives
Biomedicines·2025· 3 citedOpen Access
Multidisciplinary integrative medicine as tailored treatment for cancer patients: A multicentre, retrospective, case series study.
Journal of Clinical Oncology·2025
Association of GLP1-RA with PCSK9i as chemosensitizing method and therapy of anthracycline-induced cardiotoxicity under exposure to Ox-LDL: Biochemical and preclinical evidences.
Journal of Clinical Oncology·2025
Cardio–Renal and Systemic Effects of SGLT2i Dapagliflozin on Short-Term Anthracycline and HER-2-Blocking Agent Therapy-Induced Cardiotoxicity
Antioxidants·2025· 6 citedOpen Access
SGLT2 Inhibitors in Cancer Patients: A Comprehensive Review of Clinical, Biochemical, and Therapeutic Implications in Cardio-Oncology
International Journal of Molecular Sciences·2025· 10 citedOpen Access
COMBINATION THERAPY WITH SEMAGLUTIDE AND VERICIGUAT AS AN EFFECTIVE PREVENTIVE THERAPY OF 5-FU INDUCED CARDIOTOXICITY IN CANCER PATIENTS: PRELIMINARY EVIDENCES IN CARDIO-ONCOLOGY
Journal of the American College of Cardiology·2025Open Access
SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR DAPAGLIFLOZIN IN PRIMARY PREVENTION OF CARDIOTOXICITY INDUCED BY ANTHRACYCLINE-TRASTUZUMAB THERAPY THROUGH PAMPK, MYD88 AND NLRP-3 PATHWAYS
Journal of the American College of Cardiology·2025Open Access
VERICIGUAT PREVENTS ANTHRACYCLINE-MEDIATED CARDIOTOXICITY AND SARCOPENIA THROUGH CGMP-NLRP3-CYTOKINE PATHWAY: POTENTIAL APPLICATION IN CANCER PATIENTS
Journal of the American College of Cardiology·2025Open Access
In the Era of Cardiovascular–Kidney–Metabolic Syndrome in Cardio-Oncology: From Pathogenesis to Prevention and Therapy
Cancers·2025· 13 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Nicola Maurea(22), Massimiliano Berretta(18), Rosario Vincenzo Iaffaioli(12), Gerardo Botti(10), Alfonso Barbarisi(8), Maria Laura Canale(7), Manlio Barbarisi(7), Emilia Armenia(7), Raffaele Vecchione(6), Paolo A. Netti(6), Martina Iovine(6), Alessandro Inno(6), Antônio Barbieri(5), Andrea Paccone(5), Gaetano Facchini(5), Marino Scherillo(5), Carlo Maurea(5), Stefano Oliva(5), Domenico Gabrielli(5), Irma Bisceglia(5)